These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25027297)

  • 61. [A molecule active in deficiency and metabolic neuropathies].
    Med Chir Dig; 1982; 11(4):305-6. PubMed ID: 6287127
    [No Abstract]   [Full Text] [Related]  

  • 62. Why are there no good treatments for diabetic neuropathy?
    Malik RA
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):607-9. PubMed ID: 24746878
    [No Abstract]   [Full Text] [Related]  

  • 63. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial.
    Fonseca VA; Lavery LA; Thethi TK; Daoud Y; DeSouza C; Ovalle F; Denham DS; Bottiglieri T; Sheehan P; Rosenstock J
    Am J Med; 2013 Feb; 126(2):141-9. PubMed ID: 23218892
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [In process].
    Jäger-Becker D
    Med Monatsschr Pharm; 2016 Aug; 39(8):356-7. PubMed ID: 29984961
    [No Abstract]   [Full Text] [Related]  

  • 65. Neurotrophic factors and diabetic peripheral neuropathy.
    Apfel SC
    Eur Neurol; 1999; 41 Suppl 1():27-34. PubMed ID: 10023126
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Understanding the Signaling Pathways Related to the Mechanism and Treatment of Diabetic Peripheral Neuropathy.
    Tang HY; Jiang AJ; Ma JL; Wang FJ; Shen GM
    Endocrinology; 2019 Sep; 160(9):2119-2127. PubMed ID: 31318414
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Diabetic neuropathy--sensory abnormalities and treatment for painful neuropathy].
    Suzuki K; Toyota T
    Nihon Rinsho; 1991 Feb; 49 Suppl():180-5. PubMed ID: 1851897
    [No Abstract]   [Full Text] [Related]  

  • 68. [Effects of prostaglandin El on severe diabetic neuropathy].
    Kamio N; Ishihara H; Kondo T; Kobayashi I
    Horumon To Rinsho; 1983 Sep; 31(9):887-92. PubMed ID: 6685590
    [No Abstract]   [Full Text] [Related]  

  • 69. Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy.
    Watanabe T; Kaji R; Oka N; Bara W; Kimura J
    J Neurol Sci; 1994 Apr; 122(2):140-3. PubMed ID: 8021696
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and efficacy of intravenous ultra-high dose methylcobalamin treatment for peripheral neuropathy: a phase I/II open label clinical trial.
    Shibuya K; Misawa S; Nasu S; Sekiguchi Y; Beppu M; Iwai Y; Mitsuma S; Isose S; Arimura K; Kaji R; Kuwabara S
    Intern Med; 2014; 53(17):1927-31. PubMed ID: 25175124
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.
    Kawai T; Takei I; Tokui M; Funae O; Miyamoto K; Tabata M; Hirata T; Saruta T; Shimada A; Itoh H
    J Diabetes Complications; 2010; 24(6):424-32. PubMed ID: 19716319
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of Chinese materia medica on nerve repair and regeneration in diabetic peripheral neuropathy].
    Liang XC; Piao YL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):564-8. PubMed ID: 21608233
    [No Abstract]   [Full Text] [Related]  

  • 73. The role of glutamate in diabetic and in chemotherapy induced peripheral neuropathies and its regulation by glutamate carboxypeptidase II.
    Carozzi VA; Ceresa C
    Curr Med Chem; 2012; 19(9):1261-8. PubMed ID: 22304715
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.
    Han X; Wang L; Shi H; Zheng G; He J; Wu W; Shi J; Wei G; Zheng W; Sun J; Huang H; Cai Z
    BMC Cancer; 2017 Jan; 17(1):40. PubMed ID: 28068938
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vitamin B supplementation for diabetic peripheral neuropathy.
    Jayabalan B; Low LL
    Singapore Med J; 2016 Feb; 57(2):55-9. PubMed ID: 26892473
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus.
    Hashem MM; Esmael A; Nassar AK; El-Sherif M
    Sci Rep; 2021 Jan; 11(1):1940. PubMed ID: 33479439
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy.
    Thakur V; Sadanandan J; Chattopadhyay M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019145
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bilateral phrenic neuropathies in a diabetic patient responsive to intravenous immunoglobulin: a case report.
    Rison RA; Beydoun SR
    Clin Neurol Neurosurg; 2011 Nov; 113(9):788-91. PubMed ID: 21906870
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analysis of the effect of probucol-mecobalamin tablets combination on oxidative stress in patients with diabetic peripheral neuropathy.
    Peng HY; Gong YY
    Neurosci Lett; 2021 Jan; 741():135484. PubMed ID: 33161105
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aging and the immune response in diabetic peripheral neuropathy.
    Hagen KM; Ousman SS
    J Neuroimmunol; 2021 Jun; 355():577574. PubMed ID: 33894676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.